• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

United Therapeutics Corp

+ Add to Watchlist

UTHR:US

130.2200 USD 2.4000 1.88%

As of 17:10:00 ET on 12/24/2014.

Company Profile for United Therapeutics Corp (UTHR)

United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.

Contact Information

United Therapeutics Corp

1040 Spring Street
Silver Spring, MD 20910
United States
Phone: 1-301-608-9292
Fax: 1-301-608-9291

Key Executives for United Therapeutics Corp (UTHR)

Martine A RothblattChairman/CEO/FounderRoger A JeffsPresident/COO
John M FerrariCFO/TreasurerShola OyewoleChief Information Officer
David ZaccardelliChief Manufacturing OfficerPaul A MahonExec VP/Secy/General Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil